Clinical Trial Update: Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, oxaliplatin, and panitumumab in Kras/BRAF wild-type biliary tract cancers and gallbladder cancer has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Gallbladder Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• Vectibix (panitumumab)

Snippet

Sponsor: University of Rochester | Conditions: Biliary Tract Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-17